Samuel Refetoff to Antineoplastic Agents
This is a "connection" page, showing publications Samuel Refetoff has written about Antineoplastic Agents.
Connection Strength
0.101
-
Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression. Endocr Relat Cancer. 2014 Oct; 21(5):755-67.
Score: 0.055
-
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation. J Clin Invest. 2011 Dec; 121(12):4700-11.
Score: 0.046